| Dr An Phan, MD | |
|
4320 Diplomacy Dr, Anchorage, AK 99508-5925 | |
| (907) 563-2662 | |
| Not Available |
| Full Name | Dr An Phan |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 4320 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154857373 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MDR-7300 (Hawaii) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 173638 (Alaska) | Primary |
| Entity Name | Southeast Alaska Regional Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376758037 PECOS PAC ID: 1456265362 Enrollment ID: O20031114000631 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, today announced that positive results from a proof-of-concept clinical trial using JX-594 to treat patients with metastatic melanoma were published in the peer-reviewed journal Molecular Therapy.
Agilent Technologies Inc. today introduced GeneSpring GX 11.5, an expansion of its popular bioinformatics software into visualizing and analyzing multiple types of biological data. GeneSpring GX 11.5 now interprets exon microarray, proteomics and metabolomics experiments together for the first time, using a familiar interface.
Investigators at Johns Hopkins report they have new evidence that a bacterium known to cause chronic inflammatory gum infections also triggers the inflammatory "autoimmune" response characteristic of chronic, joint-destroying rheumatoid arthritis (RA).
Hate the Lakers? Do the Celtics make you want to hurl? Whether you like someone can affect how your brain processes their actions, according to new research from the Brain and Creativity Institute at USC.
NanoViricides, Inc. announced today that the European Medicines Agency, has awarded orphan drug designation to DengueCide, the Company's drug candidate for the treatment of dengue and dengue hemorrhagic fever.
› Verified 7 days ago
| Entity Name | Alaska Native Tribal Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, today announced that positive results from a proof-of-concept clinical trial using JX-594 to treat patients with metastatic melanoma were published in the peer-reviewed journal Molecular Therapy.
Agilent Technologies Inc. today introduced GeneSpring GX 11.5, an expansion of its popular bioinformatics software into visualizing and analyzing multiple types of biological data. GeneSpring GX 11.5 now interprets exon microarray, proteomics and metabolomics experiments together for the first time, using a familiar interface.
Investigators at Johns Hopkins report they have new evidence that a bacterium known to cause chronic inflammatory gum infections also triggers the inflammatory "autoimmune" response characteristic of chronic, joint-destroying rheumatoid arthritis (RA).
Hate the Lakers? Do the Celtics make you want to hurl? Whether you like someone can affect how your brain processes their actions, according to new research from the Brain and Creativity Institute at USC.
NanoViricides, Inc. announced today that the European Medicines Agency, has awarded orphan drug designation to DengueCide, the Company's drug candidate for the treatment of dengue and dengue hemorrhagic fever.
› Verified 7 days ago
| Entity Name | Southcentral Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, today announced that positive results from a proof-of-concept clinical trial using JX-594 to treat patients with metastatic melanoma were published in the peer-reviewed journal Molecular Therapy.
Agilent Technologies Inc. today introduced GeneSpring GX 11.5, an expansion of its popular bioinformatics software into visualizing and analyzing multiple types of biological data. GeneSpring GX 11.5 now interprets exon microarray, proteomics and metabolomics experiments together for the first time, using a familiar interface.
Investigators at Johns Hopkins report they have new evidence that a bacterium known to cause chronic inflammatory gum infections also triggers the inflammatory "autoimmune" response characteristic of chronic, joint-destroying rheumatoid arthritis (RA).
Hate the Lakers? Do the Celtics make you want to hurl? Whether you like someone can affect how your brain processes their actions, according to new research from the Brain and Creativity Institute at USC.
NanoViricides, Inc. announced today that the European Medicines Agency, has awarded orphan drug designation to DengueCide, the Company's drug candidate for the treatment of dengue and dengue hemorrhagic fever.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr An Phan, MD 4320 Diplomacy Dr, Anchorage, AK 99508-5925 Ph: () - | Dr An Phan, MD 4320 Diplomacy Dr, Anchorage, AK 99508-5925 Ph: (907) 563-2662 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, today announced that positive results from a proof-of-concept clinical trial using JX-594 to treat patients with metastatic melanoma were published in the peer-reviewed journal Molecular Therapy.
Agilent Technologies Inc. today introduced GeneSpring GX 11.5, an expansion of its popular bioinformatics software into visualizing and analyzing multiple types of biological data. GeneSpring GX 11.5 now interprets exon microarray, proteomics and metabolomics experiments together for the first time, using a familiar interface.
Investigators at Johns Hopkins report they have new evidence that a bacterium known to cause chronic inflammatory gum infections also triggers the inflammatory "autoimmune" response characteristic of chronic, joint-destroying rheumatoid arthritis (RA).
Hate the Lakers? Do the Celtics make you want to hurl? Whether you like someone can affect how your brain processes their actions, according to new research from the Brain and Creativity Institute at USC.
NanoViricides, Inc. announced today that the European Medicines Agency, has awarded orphan drug designation to DengueCide, the Company's drug candidate for the treatment of dengue and dengue hemorrhagic fever.
› Verified 7 days ago
Daniel Gregory Allen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 673 Medical Group, Jb Elmendorf-richardson, Anchorage, AK 99506 Phone: 907-580-2181 | |
Robert D Wald, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2605 Denali St, Ste 203, Anchorage, AK 99503 Phone: 907-677-9253 Fax: 907-272-1553 | |
Dr. Sheila Joyce Clark, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 207 E Northern Lights Blvd, Ste 111, Anchorage, AK 99503 Phone: 907-272-1892 Fax: 907-272-0962 | |
Dr. David Michael Henzler, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1100 E Dimond Blvd, Anchorage, AK 99515 Phone: 907-565-6000 Fax: 907-565-6001 | |
Dr. Karen Jackman, M.D Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1675 C St, Suite 117, Anchorage, AK 99501 Phone: 907-274-8281 Fax: 907-274-4055 | |
Dr. Steven Edward Koehl, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Anchorage, AK 99506 Phone: 907-580-2181 | |
Dr. Cathleen E Marshall, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3340 Providence Dr Ste A565, Anchorage, AK 99508 Phone: 907-212-2321 Fax: 907-212-8499 |